Abstract：Objective: To investigate cN0 papillary thyroid cancer patients for the first time in the treatment of routineprophylactic central lymph node dissection significance. Methods: From 2009 May to 2015 February in our hospital, 72 cases of patients with papillary thyroidcarcinoma were selected. All the patients were underwent routine prophylactic central lymph node dissection. The postoperative complications and prognosis were observed and the clinical pathological data and central lymph node metastasis were compared. Results: Postoperative pathology showed the central lymph node metastasis rate was 30.56%. tumor penetration thyroid membrane central lymph node metastasis rate was 53.33%, significantly higher than that of non penetrating 14.29%, the difference was statistically significant (P<0.05); Multiple tumors in patients with central lymph node metastasis rate was 70%,significantlyhigher than that of single tumor in 24.19% patients, the difference was statistically significant(P<0.05); The different age, gender, tumor diameter, tumor unilateral and bilateralpatientscentral lymph node metastasis rate showed no statistical significance (P > 0.05); Patients with postoperative complications in 3 cases, including 1 case of transient recurrent nerve injury, 2 cases of transient hypoparathyroidism. Patients were given aftertreatment, all symptomsinthe postoperative 2 ~ 6 months away. No deaths occurred during the follow-up period. Conclusion: cN0 papillary thyroid cancer for the first time in the treatment of routine prophylactic central lymph node dissection approach is necessary and safe.
吴旦平. cN0甲状腺乳头状癌患者首次治疗中常规行预防性中央区淋巴结清扫的意义[J]. 河北医学, 2018, 24(3): 389-393.
WU Danping. The Significance on the Patients with cN0 Papillary Thyroid Cancer for the First time Routine Prophylactic Central Lymph Node Dissection. HeBei Med, 2018, 24(3): 389-393.
[1] 邵堂雷,周伟.甲状腺乳头状癌中央区淋巴结清扫术后复发临床研究[J].中国实用外科杂志,2015,10(1):114~116. [2] Shaha A R.Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer[J].Laryngoscope,2004,114(3):393~402. [3] 张品一,张滨.甲状腺乳头状癌右侧喉返神经深层淋巴结清扫的前瞻性分析[J].中华肿瘤杂志,2014,36(2):109~114. [4] 俞甲子,王雅平.cN0甲状腺乳头状癌中央区淋巴结转移的危险因素分析[J].中华普通外科杂志,2014,29(3):195~198. [5] 刘林甲.状腺乳头状癌中央区淋巴结清扫36例临床分析[J].中国医药指南2014,10(9):98~99. [6] KimHeeyoung,Kim Seong-Jang.Thyroid incidentalomas on FDG PET/CT in patients with non-thyroid cancer-a large retrospective monocentric study[J].Onkologie,2013,36(5):260~264. [7] 郭冀鲁,李远.甲状腺乳头状癌外科诊治体会(附57例报告)[J].中国现代普通外科进展,2014,17(8):650~651. [8] Malhotra G,Upadhye TS.Unusual case of adrenal and renal metastases from papillary carcinoma of thyroid[J].Clinical nuclear medicine,2010,35(9):731~736.
2018, Vol. 24 
冀公网安备13080202000677号